The push for year-round E15 is gaining new urgency as the ethanol industry looks to secure long-term certainty after months of political churn in Washington. Growth Energy CEO Emily Skor ...

Payable Dec 5, 2025; for shareholders of record Dec 1, 2025; ex-div Dec 1, 2025. More on FlexShares Credit-Scored US Corporate Bond Index Fund Seeking Alpha’s Quant Rating on FlexShares Credit-Scored ...

As the push for higher ethanol blends accelerates, Growth Energy CEO Emily Skor says some of the most important decisions still ahead rest with the Environmental Protection Agency. She says ...

In addition to Morgan Stanley, Pharvaris also received a Buy from Cantor Fitzgerald’s Steven Seedhouse in a report issued on November 20. However, on November 14, Bank of America Securities reiterated ...

Political and market forces are converging around the U.S. biofuel industry as farmers and refiners press Washington on ...

McDonald's seems to have changed up a beloved classic, and customers aren't loving the new version of this fan-favorite menu ...

Cidara Therapeutics Inc. (NASDAQ:CDTX) is the top stock in our list of the hottest SMID-cap stocks so far in 2025 with a 717% ...

The Agriculture Department will soon roll out the second stage of the Supplemental Disaster Relief Program. We asked Richard ...

The Twins might make a reasonable attempt to compete for a playoff spot in 2026. Or they might use the season as a rebuilding ...

The analyst’s bullish stance stemmed from Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) strong financial position, alongside ...

In a report released yesterday, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $37.00. Skor covers the Healthcare sector, focusing on stocks such as ...

In Joseph Heller’s wonderful World War II novel “Catch-22,” a bombardier faces a winding conundrum as he considers his self-preservation: he will only be grounded from flying dangerous missions if he ...